Po-Chen Chu

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Topics

Cancer Stem Cells

Signaling Pathway

Top Venues

International journal of molecular sciences

Future medicinal chemistry

Journal of cachexia, sarcopenia and muscle

This page only lists publications with an associated author ORCID identifier.

Publications

Chia-Hung Tsai, Hui-Chi Huang, Kuan-Jung Lin, Jui-Ming Liu, Guan-Lin Chen, Yi-Hsien Yeh, Te Ling Lu, Hsiang-Wen Lin, Meng-Tien Lu, Po-Chen Chu
Inhibition of Autophagy Aggravates Arachis hypogaea L. Skin Extracts-Induced Apoptosis in Cancer Cells. International journal of molecular sciences 25 (2) (2024)
Chia-Hung Tsai, Hui-Chi Huang, Kuan-Jung Lin, Jui-Ming Liu, Guan-Lin Chen, Yi-Hsien Yeh, Te Ling Lu, Hsiang-Wen Lin, Meng-Tien Lu, Po-Chen Chu
Inhibition of Autophagy Aggravates Arachis hypogaea L. Skin Extracts-Induced Apoptosis in Cancer Cells. International journal of molecular sciences 25 (2) (2024)
Yu-Chieh Wu, Meng-Tien Lu, Po-Chen Chu, Chih-Shiang Chang
Novel 4-aminoquinoline analogs targeting the HIF-1α signaling pathway. Future medicinal chemistry (2023)
Kun-Chang Wu, Po-Chen Chu, Yu-Jung Cheng, Chia-Ing Li, Jingkui Tian, Hsing-Yu Wu, Szu-Hsien Wu, Yi-Chun Lai, Hsiang-Han Kao, Ao-Lin Hsu, Hsiang-Wen Lin, Chih-Hsueh Lin
Development of a traditional Chinese medicine-based agent for the treatment of cancer cachexia. Journal of cachexia, sarcopenia and muscle 13 (4) (2022)
Chia-Hung Tsai, Jing-Ru Weng, Hsiang-Wen Lin, Meng-Tien Lu, Yu-Chi Liu, Po-Chen Chu
Targeting Triple Negative Breast Cancer Stem Cells by Heat Shock Protein 70 Inhibitors. Cancers 14 (19) (2022)
Kun-Chang Wu, You-Cheng Hseu, Yu-Ching Shih, Govindan Sivakumar, Jyun-Ting Syu, Guan-Lin Chen, Meng-Tien Lu, Po-Chen Chu
Calycosin, a Common Dietary Isoflavonoid, Suppresses Melanogenesis through the Downregulation of PKA/CREB and p38 MAPK Signaling Pathways. International journal of molecular sciences 23 (3) (2022)
Po-Chen Chu, Yu-Chieh Wu, Chien-Yu Chen, Yu-Syuan Hung, Chih-Shiang Chang
Novel HIF-1α inhibitor CDMP-TQZ for cancer therapy. Future medicinal chemistry 13 (12) (2021)
I-Shan Hsieh, Balraj Gopula, Chi-Chi Chou, Hsiang-Yi Wu, Geen-Dong Chang, Wen-Jin Wu, Chih-Shiang Chang, Po-Chen Chu, Ching S Chen
Development of Novel Irreversible Pyruvate Kinase M2 Inhibitors. Journal of medicinal chemistry 62 (18) (2019)